Richard H. Grimm

42.5k total citations · 3 hit papers
135 papers, 15.1k citations indexed

About

Richard H. Grimm is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Nutrition and Dietetics. According to data from OpenAlex, Richard H. Grimm has authored 135 papers receiving a total of 15.1k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Cardiology and Cardiovascular Medicine, 35 papers in Endocrinology, Diabetes and Metabolism and 25 papers in Nutrition and Dietetics. Recurrent topics in Richard H. Grimm's work include Blood Pressure and Hypertension Studies (60 papers), Hormonal Regulation and Hypertension (23 papers) and Sodium Intake and Health (22 papers). Richard H. Grimm is often cited by papers focused on Blood Pressure and Hypertension Studies (60 papers), Hormonal Regulation and Hypertension (23 papers) and Sodium Intake and Health (22 papers). Richard H. Grimm collaborates with scholars based in United States, Canada and United Kingdom. Richard H. Grimm's co-authors include William C. Cushman, Hertzel C. Gerstein, Saul Genuth, David C. Goff, John B. Buse, J. Thomas Bigger, Robert P. Byington, Faramarz Ismail‐Beigi, Denise G. Simons‐Morton and Michael E. Miller and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

Richard H. Grimm

134 papers receiving 14.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effects of Intensive Glucose Lowering in Type 2 Diabetes

2008 5.5k citations Hertzel C. Gerstein, William C. Cushman et al. profile →
Original Papers. Success and Predictors of Blood Pressure Control in Diverse North American Settings: The Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

2002 742 citations William C. Cushman, Charles E. Ford et al. Journal of Clinical Hypertension profile →
Feasibility of Treating Prehypertension with an Angiotensin-Receptor Blocker

2006 619 citations Henry R. Black, Richard H. Grimm et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Richard H. Grimm United States	52	6.8k	6.3k	2.5k	1.5k	1.5k	135	15.1k
Hans Ibsen Denmark	49	4.3k 0.6×	12.4k 2.0×	2.1k 0.9×	1.2k 0.8×	1.4k 1.0×	261	16.8k
Joseph L. Izzo United States	43	4.1k 0.6×	11.4k 1.8×	2.2k 0.9×	1.1k 0.7×	2.0k 1.4×	186	18.2k
Paul N. Hopkins United States	63	5.7k 0.8×	5.3k 0.8×	5.0k 2.0×	2.9k 1.9×	1.4k 0.9×	295	16.2k
Seppo Lehto Finland	47	5.8k 0.9×	5.0k 0.8×	3.2k 1.3×	1.8k 1.2×	663 0.5×	129	13.1k
Franz H. Messerli United States	80	5.5k 0.8×	16.2k 2.6×	3.2k 1.3×	1.5k 1.0×	2.4k 1.7×	415	22.9k
Thomas M. MacDonald United Kingdom	57	4.3k 0.6×	4.4k 0.7×	2.6k 1.1×	856 0.6×	787 0.5×	357	12.9k
Christopher J. Bulpitt United Kingdom	55	3.1k 0.5×	8.9k 1.4×	1.7k 0.7×	754 0.5×	2.0k 1.3×	187	15.2k
Barry J. Materson United States	32	3.6k 0.5×	9.9k 1.6×	1.7k 0.7×	717 0.5×	1.8k 1.3×	109	15.3k
Mark J. Caulfield United Kingdom	50	6.2k 0.9×	8.2k 1.3×	6.0k 2.4×	2.1k 1.4×	1.5k 1.0×	170	17.2k
Robert J. Garrison United States	50	5.7k 0.8×	9.9k 1.6×	4.3k 1.7×	1.9k 1.2×	1.0k 0.7×	90	19.6k

Countries citing papers authored by Richard H. Grimm

Since Specialization

Citations

This map shows the geographic impact of Richard H. Grimm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard H. Grimm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard H. Grimm more than expected).

Fields of papers citing papers by Richard H. Grimm

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard H. Grimm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard H. Grimm. The network helps show where Richard H. Grimm may publish in the future.

Co-authorship network of co-authors of Richard H. Grimm

This figure shows the co-authorship network connecting the top 25 collaborators of Richard H. Grimm. A scholar is included among the top collaborators of Richard H. Grimm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard H. Grimm. Richard H. Grimm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Brønfort, Gert, Roni Evans, Alfred V. Anderson, et al.. (2012). Spinal manipulation, medication, or home exercise with advice for acute and subacute neck pain. Annals of Internal Medicine. 156(1). 9 indexed citations

2.

Rahman, Mahboob, Charles E. Ford, Jeffrey A. Cutler, et al.. (2012). Long-Term Renal and Cardiovascular Outcomes in Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Participants by Baseline Estimated GFR. Clinical Journal of the American Society of Nephrology. 7(6). 989–1002. 54 indexed citations

3.

Pop‐Busui, Rodica, Gregory W. Evans, Hertzel C. Gerstein, et al.. (2010). Effects of Cardiac Autonomic Dysfunction on Mortality Risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial. Diabetes Care. 33(7). 1578–1584. 349 indexed citations

4.

Grimm, Richard H.. (2010). Simultaneous treatment to attain blood pressure and lipid goals and reduced CV risk burden using amlodipine/atorvastatin single-pill therapy in treated hypertensive participants in a randomized controlled trial. Vascular Health and Risk Management. 6. 261–261. 34 indexed citations

5.

Mulrow, Cynthia D., Elaine Chiquette, Luis F. Angel, et al.. (2008). Dieting to reduce body weight for controlling hypertension in adults. Cochrane Database of Systematic Reviews. 2010(1). CD000484–CD000484. 32 indexed citations

6.

Wesa, Kathleen M. & Richard H. Grimm. (2004). Recommendations and Guidelines Regarding the Preferred Research Protocol for Investigating the Impact of an Optimal Healing Environment on Patients with Hypertension. The Journal of Alternative and Complementary Medicine. 10(supplement 1). S–245. 1 indexed citations

7.

Wesa, Kathleen M. & Richard H. Grimm. (2004). Recommendations and Guidelines Regarding the Preferred Research Protocol for Investigating the Impact of an Optimal Healing Environment on Patients with Hypertension. The Journal of Alternative and Complementary Medicine. 10(1). 245–250. 8 indexed citations

8.

Grimm, Richard H., Henry R. Black, Robert Rowen, et al.. (2002). Amlodipine versus chlorthalidone versus placebo in the treatment of stage I isolated systolic hypertension. American Journal of Hypertension. 15(1). 31–36. 15 indexed citations

9.

Grimm, Richard H., et al.. (2002). Treatment of Hypertension with Alternative Therapies (THAT) Study: a randomized clinical trial. Journal of Hypertension. 20(10). 2063–2068. 24 indexed citations

10.

Cushman, William C., Charles E. Ford, Jeffrey A. Cutler, et al.. (2002). Original Papers. Success and Predictors of Blood Pressure Control in Diverse North American Settings: The Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Journal of Clinical Hypertension. 4(6). 393–404. 742 indexed citations breakdown →

11.

Strickland, Daniel, J. Michael Sprafka, Russell V. Luepker, & Richard H. Grimm. (1994). ASSOCIATION OF ANTIHYPERTENSIVE AGENTS AND BLOOD LIPIDS IN A POPULATION-BASED SURVEY. Epidemiology. 5(1). 96–101. 6 indexed citations

12.

Hansen, Linda K., Richard H. Grimm, & James D. Neaton. (1990). The Relationship of White Blood Cell Count to Other Cardiovascular Risk Factors. International Journal of Epidemiology. 19(4). 881–888. 90 indexed citations

13.

Grimm, Richard H., et al.. (1990). A Comparison of Antihypertensive Drug Effects on the Progression of Extracranial Carotid Atherosclerosis. Drugs. 40(Supplement 2). 38–43. 16 indexed citations

14.

Grimm, Richard H., et al.. (1988). The role of physicians in a community-wide program for prevention of cardiovascular disease: the Minnesota Heart Health Program.. PubMed. 103(4). 360–5. 30 indexed citations

15.

Stamler, Jeremiah, Ronald J. Prineas, James D. Neaton, et al.. (1987). Background and design of the new U.S. trial on diet and drug treatment of “mild” hypertension (TOMHS). The American Journal of Cardiology. 59(14). G51–G60. 67 indexed citations

16.

Neaton, James D., Richard H. Grimm, & Jeffrey A. Cutler. (1987). Recruitment of participants for the Multiple Risk Factor Intervention Trial (MRFIT). Controlled Clinical Trials. 8(4). 41–53. 79 indexed citations

17.

Grimm, Richard H.. (1986). The White Blood Cell Count as a Risk Factor-Reply. JAMA. 255(14). 1877–1877. 1 indexed citations

18.

Grimm, Richard H., et al.. (1985). Beneficial effects from systematic dosage reduction of the diuretic, chlorthalidone: A randomized study within a clinical trial. American Heart Journal. 109(4). 858–864. 15 indexed citations

19.

Lasser, Norman L., Gregory Grandits, Arlene W. Caggiula, et al.. (1984). Effects of antihypertensive therapy on plasma lipids and lipoproteins in the multiple risk factor intervention trial. The American Journal of Medicine. 76(2). 52–65. 140 indexed citations

20.

Grimm, Richard H., Russell V. Luepker, Henry L. Taylor, & H Blackburn. (1982). Long-term effects of a blood pressure survey on patient treatment in a community.. Circulation. 65(5). 946–950. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact